Institute for Molecular Engineering, The University of Chicago, Chicago, IL 60637, USA.
Chem Soc Rev. 2017 Oct 30;46(21):6553-6569. doi: 10.1039/c7cs00536a.
Proteins and their interactions in and out of cells must be well-orchestrated for the healthy functioning and regulation of the body. Even the slightest disharmony can cause diseases. Therapeutic peptides are short amino acid sequences (generally considered <50 amino acids) that can naturally mimic the binding interfaces between proteins and thus, influence protein-protein interactions. Because of their fidelity of binding, peptides are a promising next generation of personalized medicines to reinstate biological harmony. Peptides as a group are highly selective, relatively safe, and biocompatible. However, they are also vulnerable to many in vivo pharmacologic barriers limiting their clinical translation. Current advances in molecular, chemical, and nanoparticle engineering are helping to overcome these previously insurmountable obstacles and improve the future of peptides as active and highly selective therapeutics. In this review, we focus on self-assembled vehicles as nanoparticles to carry and protect therapeutic peptides through this journey, and deliver them to the desired tissue.
蛋白质及其在细胞内外的相互作用必须协调良好,才能使身体保持健康和正常运作。即使是最微小的失调也可能导致疾病。治疗性肽是短的氨基酸序列(通常被认为小于 50 个氨基酸),可以自然模拟蛋白质之间的结合界面,从而影响蛋白质-蛋白质相互作用。由于其结合的保真度,肽是下一代有前途的个性化药物,可以恢复生物平衡。肽作为一个整体具有高度选择性、相对安全性和生物相容性。然而,它们也容易受到许多体内药理障碍的限制,这些障碍限制了它们的临床转化。目前,分子、化学和纳米颗粒工程的进步正在帮助克服这些以前无法克服的障碍,并改善肽作为活性和高度选择性治疗药物的未来。在这篇综述中,我们重点介绍自组装载体作为纳米颗粒,通过这一过程携带和保护治疗性肽,并将其递送到所需的组织。